4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-23-073069
Chief Executive Officer sold 13,237 shares at $3.63 ($48,050)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2023-12-26 | Sale | −13,237 | $3.63 | $48,050 | 596,721 | D |
| Open-market sales · 13,237 sh · avg $3.63 · $48,050 | |||||||
Loading xslF345X05/ownership.xml…